HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 913912Generated: November 4, 2026
Thionyl Chloride → HCID 67405110, compound
https://huagongshe.com/reaction/913912
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Thionyl Chloride | HCID 24386 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Tert-butyl 4-(hydroxymethyl)-4-phenylpiperidine-1-carboxylate | HCID 9994433 | — |
| Reactant | HCID 57545981 | HCID 57545981 | — |
| Reactant | HCID 57546192 | HCID 57546192 | — |
| Reactant | HCID 67403042 | HCID 67403042 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 67405110 | HCID 67405110 | — |
Reaction Steps
The conversion of the alcohol to chloromethyl derivative and the subsequent alkylation were done using similar procedure as described in the synthesis of tert-butyl 4-(((5-bromo-1-(cyclopropylmethyl)-1H-benzo[d]imidazol-2-yl)methoxy)methyl)-4-phenylpiperidine-1-carboxylate (5) and tert-butyl 4-(((6-bromo-1-(cyclopropylmethyl)-1H-benzo[d]imidazol-2-yl)methoxy)methyl)-4-phenylpiperidine-1-carboxylate. (6-(Trifluoromethyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-benzo[d]imidazol-4-yl)methanol (25 mg, 0.072 mmol) was converted to chloromethyl derivative as described in the synthesis of tert-butyl 4-(((5-bromo-1-(cyclopropylmethyl)-1H-benzo[d]imidazol-2-yl)methoxy)methyl)-4-phenylpiperidine-1-carboxylate and tert-butyl 4-(((6-bromo-1-(cyclopropylmethyl)-1H-benzo[d]imidazol-2-yl)methoxy)methyl)-4-phenylpiperidine-1-carboxylate using thionyl chloride (0.030 mL, 5.7 eq) and the crude chloromethyl derivative was alkylated with tert-butyl 4-(hydroxymethyl)-4-phenylpiperidine-1-carboxylate (25.2 mg, 1.2 eq) using sodium hydride (9 equiv) in tetrahydrofuran (3 mL) at ambient temperature for 3 days. The crude product was purified by silica gel chromatography using a gradient of 10%-80% ethyl acetate in dichloromethane. Fractions containing required compound were combined and evaporated in vacuo to give tert-butyl 4-phenyl-4-(((6-(trifluoromethyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-benzo[d]imidazol-4-yl)methoxy)methyl)piperidine-1-carboxylate (25 mg) containing required product and piperidinyl alcohol reagent in the ratio of 2:3 by proton NMR. Material used without additional purification. LC/MS (HPLC method 8): tR=3.8 min, 642(MNa)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08026257B2 |
|---|
| Source dataset | uspto-grants-2011_09 |
|---|
| ORD ID | ord-c35918ab2f5147baad958cb7d76c4f88 |
|---|
| Source note | uspto-grants-2011_09 |
|---|